Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 15;17(1):40.
doi: 10.5334/gh.1128. eCollection 2022.

Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study

Dorairaj Prabhakaran  1 , Kavita Singh  2   3 , Dimple Kondal  4 , Lana Raspail  5 , Bishav Mohan  6 , Toru Kato  7   8 , Nizal Sarrafzadegan  9 , Shamim Hayder Talukder  10 , Shahin Akter  11 , Mohammad Robed Amin  12 , Fastone Goma  13 , Juan Gomez-Mesa  14 , Ntobeko Ntusi  15 , Francisca Inofomoh  16 , Surender Deora  17 , Evgenii Philippov  18 , Alla Svarovskaya  19 , Alexandra Konradi  20 , Aurelio Puentes  21 , Okechukwu S Ogah  22 , Bojan Stanetic  23 , Aurora Issa  24 , Friedrich Thienemann  25 , Dafsah Juzar  26   27 , Ezequiel Zaidel  28 , Sana Sheikh  29 , Dike Ojji  30 , Carolyn S P Lam  31   32 , Junbo Ge  33 , Amitava Banerjee  34 , L Kristin Newby  35 , Antonio Luiz P Ribeiro  36 , Samuel Gidding  5 , Fausto Pinto  37 , Pablo Perel  38 , Karen Sliwa  39 ; WHF COVID-19 Study Collaborators
Affiliations

Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study

Dorairaj Prabhakaran et al. Glob Heart. .

Erratum in

Abstract

Background and aims: Limited data exist on the cardiovascular manifestations and risk factors in people hospitalized with COVID-19 from low- and middle-income countries. This study aims to describe cardiovascular risk factors, clinical manifestations, and outcomes among patients hospitalized with COVID-19 in low, lower-middle, upper-middle- and high-income countries (LIC, LMIC, UMIC, HIC).

Methods: Through a prospective cohort study, data on demographics and pre-existing conditions at hospital admission, clinical outcomes at hospital discharge (death, major adverse cardiovascular events (MACE), renal failure, neurological events, and pulmonary outcomes), 30-day vital status, and re-hospitalization were collected. Descriptive analyses and multivariable log-binomial regression models, adjusted for age, sex, ethnicity/income groups, and clinical characteristics, were performed.

Results: Forty hospitals from 23 countries recruited 5,313 patients with COVID-19 (LIC = 7.1%, LMIC = 47.5%, UMIC = 19.6%, HIC = 25.7%). Mean age was 57.0 (±16.1) years, male 59.4%, pre-existing conditions included: hypertension 47.3%, diabetes 32.0%, coronary heart disease 10.9%, and heart failure 5.5%. The most frequently reported cardiovascular discharge diagnoses were cardiac arrest (5.5%), acute heart failure (3.8%), and myocardial infarction (1.6%). The rate of in-hospital deaths was 12.9% (N = 683), and post-discharge 30 days deaths was 2.6% (N = 118) (overall death rate 15.1%). The most common causes of death were respiratory failure (39.3%) and sudden cardiac death (20.0%). The predictors of overall mortality included older age (≥60 years), male sex, pre-existing coronary heart disease, renal disease, diabetes, ICU admission, oxygen therapy, and higher respiratory rates (p < 0.001 for each). Compared to Caucasians, Asians, Blacks, and Hispanics had almost 2-4 times higher risk of death. Further, patients from LIC, LMIC, UMIC versus. HIC had 2-3 times increased risk of death.

Conclusions: The LIC, LMIC, and UMIC's have sparse data on COVID-19. We provide robust evidence on COVID-19 outcomes in these countries. This study can help guide future health care planning for the pandemic globally.

Keywords: COVID-19; cardiovascular disease; mortality.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare.

Figures

Participating countries and patient recruitment in the WHF COVID-19 study
Figure 1
Participating countries and patient recruitment in the WHF COVID-19 study. N = number of patients recruited in the study by participating country.
Comparison of in-hospital deaths and post-discharge 30-day deaths among COVID-19 patients by ethnic groups
Figure 2a
Comparison of in-hospital deaths and post-discharge 30-day deaths among COVID-19 patients by ethnic groups. * p < 0.001 for in-hospital deaths between Caucasians vs. Hispanics, Blacks, and Asians. * P < 0.001 for post-discharge 30-day deaths between Caucasians vs. Middle Eastern and Asians.
Comparison of in-hospital deaths and post-discharge 30-day deaths in COVID-19 patients by World Bank income groups
Figure 2b
Comparison of in-hospital deaths and post-discharge 30-day deaths in COVID-19 patients by World Bank income groups. * p < 0.001 for both in-hospital deaths and post-discharge 30-day deaths between HIC vs. LIC, LMIC, and UMIC. HIC = high income countries; UMIC = upper middle-income countries; LMIC = lower middle-income countries; LIC = low-income countries.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thienemann F, Pinto F, Grobbee DE, et al. World Heart Federation Briefing on Prevention: Coronavirus Disease 2019 (COVID-19) in Low-Income Countries. Glob Heart. 2020; 15(1): 31. [published Online first: 4 June 2020]. DOI: 10.5334/gh.778 - DOI - PMC - PubMed
    1. Hopman J, Allegranzi B, Mehtar S. Managing COVID-19 in Low- and Middle-Income Countries. JAMA. 2020; 323(16): 1549–50. [published Online first: 17 March 2020]. DOI: 10.1001/jama.2020.4169 - DOI - PubMed
    1. Angrup A, Kanaujia R, Ray P, et al. Healthcare facilities in low- and middle-income countries affected by COVID-19: Time to upgrade basic infection control and prevention practices. Indian J Med Microbiol. 2020; 38(2): 139–43. [published Online first: 05 September 2020]. DOI: 10.4103/ijmm.IJMM_20_125 - DOI - PMC - PubMed
    1. Grasselli G, Greco M, Zanella A, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020; 180(10): 1345–55. [published Online first: 16 July 2020]. DOI: 10.1001/jamainternmed.2020.3539 - DOI - PMC - PubMed
    1. Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8): 782–93. [published Online first: 11 July 2020]. DOI: 10.1001/jama.2020.12839 - DOI - PubMed

Publication types